BOMBAY BURMAH TRADING CORPORATION
Back to All Ratios
|
BOMBAY BURMAH TRADING CORPORATION Last 5 Year Core EBITDA Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Core EBITDA Margin(%) | 16.33 | 17.25 | 16.02 | 14.60 | 17.22 |
What is the latest Core EBITDA Margin ratio of BOMBAY BURMAH TRADING CORPORATION ?
| Year | Core EBITDA Margin |
|---|---|
| Mar2025 | 16.33 |
| Mar2024 | 17.25 |
| Mar2023 | 16.02 |
| Mar2022 | 14.60 |
| Mar2021 | 17.22 |
How is Core EBITDA Margin of BOMBAY BURMAH TRADING CORPORATION Trending?
| Years | Core EBITDA Margin | % Change | |
|---|---|---|---|
| Mar2025 | 16.33 | -5.33 | |
| Mar2024 | 17.25 | 7.68 | |
| Mar2023 | 16.02 | 9.73 | |
| Mar2022 | 14.6 | -15.21 | |
| Mar2021 | 17.22 | - | |
Other Financial Ratios of BOMBAY BURMAH TRADING CORPORATION
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Margin ratio of peers of BOMBAY BURMAH TRADING CORPORATION
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BOMBAY BURMAH TRADING CORPORATION | ₹13,298.3 Cr | -4.4% | -0.4% | -29.2% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,390.6 Cr | 1.3% | -1.1% | 13.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,142.8 Cr | -2% | -0% | -15% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,251.9 Cr | -1.5% | -5.5% | -25.4% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹476.9 Cr | -1.6% | -17.7% | 19.5% | Stock Analytics | |
| INDO US BIOTECH | ₹262.1 Cr | -2.9% | -2% | -44.2% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BOMBAY BURMAH TRADING CORPORATION | -4.4% |
-0.4% |
-29.2% |
| SENSEX | -2% |
2.6% |
4.2% |
You may also like the below Video Courses